Industry News
Oxford BioTherapeutics And Boehringer Ingelheim Enter Collaboration To Discover Novel Antibody Targets In Cancer
May 01, 2013
Oxford BioTherapeutics (OBT) and Boehringer Ingelheim(BI) have announced a new alliance focused on the discovery of novel cancer antibody targets that OBT will identify with the help of its OGAP(R) discovery platform... Read More
Mapping Of Cancer Cell Fuel Pumps Paves The Way For New Drugs
May 01, 2013
For the first time, researchers at Karolinska Institutet in Sweden have managed to obtain detailed images of the way in which the transport protein GLUT transports sugars into cells... Read More
Scientists Discover How A Protein Finds Its Way
May 01, 2013
Proteins, the workhorses of the body, can have more than one function, but they often need to be very specific in their action or they create cellular havoc, possibly leading to disease. Scientists from the Florida campus of The Scripps Research Institute (TSRI) have uncovered how an enzyme co-factor can bestow specificity on a class of proteins with otherwise nonspecific biochemical activity... Read More
Researchers Unveil Technique For Easy Comparisons Of Proteins In Solution
May 01, 2013
A revolutionary X-ray analytical technique that enables researchers at a glance to identify structural similarities and differences between multiple proteins under a variety of conditions has been developed by researchers with the U.S. Department of Energy (DOE)'s Lawrence Berkeley National Laboratory (Berkeley Lab)... Read More
Breast Implants Can Hinder Breast Cancer Survival In Women
May 01, 2013
Cosmetic breast implants may hinder survival in women who later develop breast cancer, according to a new small study published in BMJ. The authors suggest that these results be interpreted with caution because some of the twelve studies that were looked into did not adjust for a number of confounding elements... Read More
Prognostic RNA Markers Identified In A Common Form Of Breast Cancer
May 01, 2013
A Big-Data analysis that integrates three large sets of genomic data available through The Cancer Genome Atlas has identified 37 RNA molecules that might predict survival in patients with the most common form of breast cancer. The study by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J... Read More
The Real Life Costs Of Postcode Inequality For Cancer Diagnosis In The UK
May 01, 2013
Study finds hundreds of lives could be prolonged if women in poorer areas were diagnosed with breast cancer at same stage as those in affluent areas Hundreds of women with breast cancer living in England's most deprived areas would have better survival rates if they were diagnosed at the same stage as those who lived in affluent areas... Read More
Women Smokers Have Higher Colon Cancer Risk Than Men
Apr 30, 2013
Smoking increases the risk of developing colon cancer in both males and females, however, the risk is higher among women smokers, according to a new study. The research was conducted by a team of experts from the University of Tromsø in Norway and was published in Cancer Epidemiology, Biomarkers & Prevention... Read More
Dark Field Imaging Of Rattle-Type Silica Nanorattles Coated Gold Nanoparticles In Vitro And In Vivo
Apr 30, 2013
In recent years, metal nanoparticles have showed great application prospect in the field of biological imaging, cancer diagnosis and treatment due to its unique optical scattering and optical absorption properties. In many metal materials, gold nanoparticles have caused concerns in the field because of its simple preparation, easy to modify advantages... Read More
Positive CHMP Opinion For Xtandi™ (Enzalutamide) In Advanced Prostate Cancer
Apr 30, 2013
Enzalutamide recommended for approval in the European Union (EU) for the treatment of adult men with metastatic castration-resistant prostate cancer whose disease has progressed on or after docetaxel therapy 1 Astellas Pharma Europe Ltd., the European Headquarters of Tokyo-based Astellas Pharma Inc. (TSE:4503), and Medivation, Inc... Read More
Previous Page Next Page